Novocure (NVCR) reported Q1 EPS of ($0.04), $0.14 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $137.5 million versus the consensus estimate of $134.08 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.